These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 11522872

  • 1. Sevelamer hydrochloride (Renagel), a non-calcaemic phosphate binder, arrests parathyroid gland hyperplasia in rats with progressive chronic renal insufficiency.
    Nagano N, Miyata S, Obana S, Ozai M, Kobayashi N, Fukushima N, Burke SK, Wada M.
    Nephrol Dial Transplant; 2001 Sep; 16(9):1870-8. PubMed ID: 11522872
    [Abstract] [Full Text] [Related]

  • 2. Sevelamer hydrochloride, a calcium-free phosphate binder, inhibits parathyroid cell proliferation in partially nephrectomized rats.
    Nagano N, Miyata S, Obana S, Kobayashi N, Abe M, Fukushima N, Wada M.
    Nephrol Dial Transplant; 2003 Jun; 18 Suppl 3():iii81-5. PubMed ID: 12771309
    [Abstract] [Full Text] [Related]

  • 3. Sevelamer hydrochloride reverses parathyroid gland enlargement via regression of cell hypertrophy but not apoptosis in rats with chronic renal insufficiency.
    Nagano N, Miyata S, Abe M, Wakita S, Kobayashi N, Wada M.
    Nephrol Dial Transplant; 2006 Mar; 21(3):634-43. PubMed ID: 16169864
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Sevelamer with and without calcium and vitamin D: observations from a long-term open-label clinical trial.
    Chertow GM, Dillon MA, Amin N, Burke SK.
    J Ren Nutr; 2000 Jul; 10(3):125-32. PubMed ID: 10921533
    [Abstract] [Full Text] [Related]

  • 9. Influence of sevelamer hydrochloride on serum concentration of whole (1-84) and N-terminally truncated (7-84) parathyroid hormone fragments in hemodialysis uremic patients.
    Chudek J, Piecha G, Kokot F, Wiecek A.
    J Nephrol; 2003 Jul; 16(5):710-5. PubMed ID: 14733418
    [Abstract] [Full Text] [Related]

  • 10. The impact of improved phosphorus control: use of sevelamer hydrochloride in patients with chronic renal failure.
    Amin N.
    Nephrol Dial Transplant; 2002 Feb; 17(2):340-5. PubMed ID: 11812903
    [Abstract] [Full Text] [Related]

  • 11. Sevelamer hydrochloride suppresses proliferation of parathyroid cells during the early phase of chronic renal failure in rats.
    Xiao X, Liu Y, Zhong X, Liu Y, Zhou D, Xiong X, Ran J.
    Nephrology (Carlton); 2019 Jan; 24(1):127-133. PubMed ID: 29278442
    [Abstract] [Full Text] [Related]

  • 12. Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremia.
    Cozzolino M, Staniforth ME, Liapis H, Finch J, Burke SK, Dusso AS, Slatopolsky E.
    Kidney Int; 2003 Nov; 64(5):1653-61. PubMed ID: 14531797
    [Abstract] [Full Text] [Related]

  • 13. Sevelamer hydrochloride prevents ectopic calcification and renal osteodystrophy in chronic renal failure rats.
    Katsumata K, Kusano K, Hirata M, Tsunemi K, Nagano N, Burke SK, Fukushima N.
    Kidney Int; 2003 Aug; 64(2):441-50. PubMed ID: 12846739
    [Abstract] [Full Text] [Related]

  • 14. Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro.
    Slatopolsky E, Finch J, Denda M, Ritter C, Zhong M, Dusso A, MacDonald PN, Brown AJ.
    J Clin Invest; 1996 Jun 01; 97(11):2534-40. PubMed ID: 8647946
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Pharmacological and clinical trial data on a novel phosphate-binding polymer (sevelamer hydrochloride), a medicine for hyperphosphatemia in hemodialysis patients].
    Nagano N, Fukushima N.
    Nihon Yakurigaku Zasshi; 2003 Nov 01; 122(5):443-53. PubMed ID: 14569164
    [Abstract] [Full Text] [Related]

  • 18. Meta-analysis of the effect of sevelamer on phosphorus, calcium, PTH, and serum lipids in dialysis patients.
    Burke SK, Dillon MA, Hemken DE, Rezabek MS, Balwit JM.
    Adv Ren Replace Ther; 2003 Apr 01; 10(2):133-45. PubMed ID: 12879374
    [Abstract] [Full Text] [Related]

  • 19. RenaGel, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone. The RenaGel Study Group.
    Slatopolsky EA, Burke SK, Dillon MA.
    Kidney Int; 1999 Jan 01; 55(1):299-307. PubMed ID: 9893140
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.